Neurologist Letter Reveals Senasa Defendant Santiago Hazim Requires New York MS Treatment to Avoid Prison

A neurologist’s letter has become a focal point in the ongoing Senasa corruption case, asserting that Santiago Hazim, one of the accused, requires specialized treatment for multiple sclerosis in New York.

Dr. Luis Taveras Guzmán, the signing physician, reports that the 59‑year‑old defendant has a history of cardiovascular problems and a confirmed diagnosis of multiple sclerosis, a disease that demands continual, specialized care abroad.

The letter also notes that Hazim has suffered from cardiac arrhythmia since February 2011, with earlier similar episodes recorded in 1988 and 2007, though none led to major cardiovascular complications. Additionally, he experienced spontaneous intestinal obstructions in November 2010 and January 2011.

Following the emergence of atypical neurological symptoms, Hazim underwent magnetic resonance imaging of the brain and spinal cord. The findings prompted his travel to the United States, where neurologists at Mount Sinai Medical Center in New York confirmed the multiple sclerosis diagnosis and initiated therapy with ocrelizumab (Ocrevus).

Legal context

• The defense is using the medical document to counter the Public Ministry’s request for 18 months of preventive detention for Hazim and the other nine co‑accused.

Attorney Miguel Valerio submitted the report, arguing that Hazim must receive the ocrelizumab infusion every six months, a regimen that obliges him to travel to New York twice a year, making detention impractical.

On Friday afternoon, prosecutors and defense counsel presented their arguments before Judge Rigoberto Sena. After the exchanges, the judge retired to consider a verdict.

Frequently Asked Questions

What medical condition does Santiago Hazim have?

He has been diagnosed with multiple sclerosis, a chronic neurological disease that requires specialized treatment and regular monitoring.

Why is the defense seeking to avoid preventive detention?

The defense argues that Hazim needs to travel to New York twice a year for six‑month ocrelizumab infusions, making detention incompatible with his medical regimen.

What is the current status of the case?

Prosecutors and the defense have presented their arguments to Judge Rigoberto Sena, who is now deliberating before issuing a verdict.

How do you think the court should balance the health needs of an accused with the demands of justice?